ask="4.65"
ask_size="800"
average_daily_volume="228748"
bid="4.21"
bid_size="10000"
book_value="0.74"
change="+0.46"
change_from_200_day_moving_average="1.62"
change_from_50_day_moving_average="1.11"
change_from_52_week_high="-0.21"
change_From_52_week_low="3.07"
change_in_percent="+11.27%"
close="4.54"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.58"
high_52_weeks="4.75"
last_trade_date="3/9/2017"
last_trade_price="4.54"
last_trade_size="696"
last_trade_time="4:00pm"
low="4.07"
low_52_weeks="1.47"
market_capitalization="155.03M"
moving_average_200_day="2.92"
moving_average_50_day="3.43"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="6.75"
open="4.16"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+55.35%"
percent_change_from_50_day_moving_average="+32.31%"
percent_change_from_52_week_high="-4.42%"
percent_change_from_52_week_low="+208.84%"
previous_close="4.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.49"
price_per_sales="31.30"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="2.29"
stock_exchange="NGM"
symbol="FATE"
volume="775776"
weeks_range_52="1.47 - 4.75"
